$KURA News

Will Kura Oncology (KURA) Report Negative Q3 Earnings? What You Should Know

Kura Oncology Launches $50M-Backed Diabetes Venture for Oral Menin Inhibitor

Kura Oncology, Inc. (KURA) Discusses KO-7246 Data and Development Strategy for Menin Inhibitors in Diabetes - Slideshow

Kura Oncology, Inc. (KURA) Discusses KO-7246 Data and Development Strategy for Menin Inhibitors in Diabetes Transcript

Caspian Therapeutics and Kura Oncology to Host Investor Webcast Highlighting Caspian’s Launch and KO-7246 Preclinical Data in Diabetes

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

JP Morgan Initiates Coverage On Kura Oncology with Overweight Rating, Announces Price Target of $30

Caspian Therapeutics And Kura Oncology Released Comprehensive Preclinical Data Supporting KO-7246 For Diabetes

Kura Oncology Q2 2026 Earnings Call Transcript

Kura Oncology, Inc. (KURA) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer

Kura Oncology Appoints Jennifer Fulk As CFO, Effective September 8

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Kura Oncology (KURA) Stock Looks Fully Priced After Its 56% Run

KURA Stock Gains 37.6% in a Month: Here's What You Need to Know

Kura Oncology to Participate in Three Investor Conferences in September

Kura Oncology (KURA) Upgraded to Buy: What Does It Mean for the Stock?

Cancer Biotech Kura Oncology Rallies to New High After CEO’s Stock Purchase

Kura Oncology: 'Strong Buy': Ziftomenib AML Expansions With Different Regimens Could Boost KOMZIFTI's Prospects

KURA Stock Hits Fresh 52-Week High As CEO Buys More Shares — Retail Wonders If Wilson Is Following Moderna CEO’s Playbook